Visiting Fellow in Bioethics, Ethics & Public Policy Center
Alexander Raikin is a Visiting Fellow in the Bioethics, Technology and Human Flourishing Program at the Ethics and Public Policy Center. His research focuses on the dignity of human life and end-of-life issues, especially on its impact on the field of medicine and broader ethical questions of social belonging.
For tips, please send an email to araikin+tips@eppc.org.
His writing has been widely cited in major publications such as The Atlantic and the New York Times and in academic journals in the United States, Canada, UK, and France. He wrote cover stories for National Review and The New Atlantis, while his other bylines include City Journal, Plough, and the Washington Free Beacon. Raikin frequently speaks on national radio and on major podcasts.
Last year, Raikin was an inaugural Richard John Neuhaus Fellow at the Public Interest Fellowship and EPPC. He was a Tikvah Summer Fellow and a Killam scholar with Fulbright at American University. He graduated from Carleton University with a bachelor’s degree in public policy. Raikin is a proud member of Kesher Israel synagogue and lives with his wife in Washington, D.C.
Senior Fellow, Cato Institute
Jeffrey A. Singer is a senior fellow at the Cato Institute and works in the Department of Health Policy Studies. He is principal and founder of Valley Surgical Clinics Ltd., the largest and oldest group private surgical practice in Arizona, and has been in private practice as a general surgeon for more than 35 years.
He is also a visiting fellow at the Goldwater Institute in Phoenix. Singer is a member of the Board of Scientific Advisors of the American Council on Science and Health. From 1994 to 2016, he was a regular contributor to Arizona Medicine, the journal of the Arizona Medical Association. He served on the Advisory Board Council of the Center for Political Thought and Leadership at Arizona State University from 2014 to 2018 and is an adjunct instructor in the Program on Political History and Leadership at ASU. He writes and speaks extensively on regional and national public policy, with a specific focus on the areas of health care policy and the harmful effects of drug prohibition.
He received his BA from Brooklyn College (City University of New York) and his MD from New York Medical College. He is a fellow of the American College of Surgeons.
Managing Director, Berkeley Research Group
Dan Troy is Managing Director and an expert witness on FDA matters at Berkeley Research Group. Previously he served as Chief Counsel of the US Food and Drug Administration and General Counsel of GlaxoSmithKline PLC.
Senior Fellow, Competitive Enterprise Institute
Joel M. Zinberg, M.D., J.D. is a senior fellow with the Competitive Enterprise Institute. He is a native New Yorker who recently completed two years as General Counsel and Senior Economist at the Council of Economic Advisers in the Executive Office of the President. He practiced general and oncologic surgery in New York for nearly 30 years at the Mount Sinai Hospital and Icahn School of Medicine where he is an Associate Clinical Professor of Surgery. He has been involved with health policy issues and the interaction between law and medicine for his entire career. Dr. Zinberg taught for 10 years at the Columbia University Law School as a Lecturer in Law where he created a course on the legal, policy and ethical issues surrounding organ transplantation. He served for many years on the New York State Board of Professional Medical Conduct and on Mount Sinai's Ethics Committee and Institutional Review Board. He is past President and Trustee of the New York County Medical Society. Between 2015 and 2017 he was a Visiting Scholar at the American Enterprise Institute.
Dr. Zinberg has written for publications as varied as the Journal of the American Medical Association, the Bulletin of the American College of Surgeons, the Wall Street Journal, City Journal and law reviews. He is the author of book chapters on legal and policy issues in organ transplantation.
He received his J.D. degree from the Yale Law School, his M.D. from the Columbia University College of Physicians and Surgeons and his B.A. in economics with High Honors, Phi Beta Kappa, from Swarthmore College.
Senior Fellow, Competitive Enterprise Institute
Joel M. Zinberg, M.D., J.D. is a senior fellow with the Competitive Enterprise Institute. He is a native New Yorker who recently completed two years as General Counsel and Senior Economist at the Council of Economic Advisers in the Executive Office of the President. He practiced general and oncologic surgery in New York for nearly 30 years at the Mount Sinai Hospital and Icahn School of Medicine where he is an Associate Clinical Professor of Surgery. He has been involved with health policy issues and the interaction between law and medicine for his entire career. Dr. Zinberg taught for 10 years at the Columbia University Law School as a Lecturer in Law where he created a course on the legal, policy and ethical issues surrounding organ transplantation. He served for many years on the New York State Board of Professional Medical Conduct and on Mount Sinai's Ethics Committee and Institutional Review Board. He is past President and Trustee of the New York County Medical Society. Between 2015 and 2017 he was a Visiting Scholar at the American Enterprise Institute.
Dr. Zinberg has written for publications as varied as the Journal of the American Medical Association, the Bulletin of the American College of Surgeons, the Wall Street Journal, City Journal and law reviews. He is the author of book chapters on legal and policy issues in organ transplantation.
He received his J.D. degree from the Yale Law School, his M.D. from the Columbia University College of Physicians and Surgeons and his B.A. in economics with High Honors, Phi Beta Kappa, from Swarthmore College.
Comfort Care or Hastened Death? Assisted Suicide and the Medicare Hospice Benefit
Alexander Raikin, Jeffrey A. Singer, Daniel E. Troy
Assisted suicide is a contested issue in American law and medicine, raising questions over individual...
Explainer 62 - FDA's Regulation of Laboratory Developed Tests
Joel Zinberg
For many years FDA has claimed the authority to regulate Laboratory Developed Tests, that is...
Explainer Episode 48 - The FDA & the Practice of Medicine: Possible Regulation of Off-Label Prescriptions
Joel Zinberg
On December 29, 2022, President Biden signed the Consolidated Appropriations Act, 2023 into law. This omnibus law...